MetaCap

Polyrizon (PLRZ) vs Xtant Medical (XTNT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Polyrizon (PLRZ) has outperformed Xtant Medical (XTNT) over the past year, gaining 144.0% versus a loss of 66.1%. Xtant Medical is the larger company by market cap ($29.5 million vs $22.6 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PLRZ+143.97%XTNT-66.13%
+371%+142%-88%
Nov 21, 20251 yearNov 20, 2026
PLRZ-99.47%XTNT-60.38%
+74%-17%-108%
Oct 28, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PLRZ versus XTNT key metrics
MetricPLRZXTNT
Share price$9.31$0.21
Market cap$22.61M$29.49M
1-day change-8.42%-2.82%
YTD return+9.66%-73.08%
1-year return+143.97%-66.13%
5-year return—-73.08%
EPS (TTM)$-4.97$-0.11
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$133.93M
Revenue growth (YoY)—+14.21%
Net income (latest FY)$-3.33M$4.97M
Gross margin—62.92%
Operating margin—5.44%
Net margin—3.71%
52-week high$18.20$0.84
52-week low$2.88$0.17
Distance from 52-week high-48.85%-75.00%
Analyst consensus—none
Avg. price target upside—+390.48%
Average volume38.21K1.69M
Shares outstanding2.43M140.45M
Employees2151
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • PLRZ has outperformed XTNT by 210.1 percentage points over the past year.

About Polyrizon

PLRZ stock →

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients.

Health Care · Medical/Dental Instruments · 2 employees

About Xtant Medical

XTNT stock →

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.

Health Care · Medical/Dental Instruments · 151 employees

PLRZ vs XTNT FAQ

Which is bigger, Polyrizon or Xtant Medical?

Xtant Medical (XTNT) is larger, with a market capitalization of $29.49M compared with $22.61M for Polyrizon (PLRZ).

Which stock has performed better over the past year, PLRZ or XTNT?

PLRZ returned +143.97% over the past 12 months, compared with -66.13% for XTNT (price return, excluding dividends). Past performance does not predict future results.

Are Polyrizon and Xtant Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons